Especially, are EVs with a high expression of PD-L1 potential biomarkers for the diagnosis or prognosis of MPN, similar to what has been demonstrated with circulating exosomal-PD-L1 in lung cancer, breast cancer [146], melanoma [147,148], and head and neck cancer [149,150]? This evidence concerns the gene CD274 and myeloproliferative neoplasm.